Erik Tyrrell-Knott

As Alveo’s Chief Business and Strategy Officer, Erik Tyrrell-Knott leads business development, sales, partnering and product management efforts, driving the Company’s commercial and go-to-market strategies. With more than 20 years of experience in strategic business development for medical device and diagnostic companies ranging from start-ups to mature global corporations, Erik most recently served as Vice President of Business Development at Atonarp, Inc, and previously as Head of Business Development for Thermo Fisher Scientific, following the acquisition of Mesa Biotech, innovator of the Accula RT PCR point-of-care testing platform, where he had served as Senior Vice President of Business Development and Product Management. Prior to Mesa, Erik served as Vice President of Business Development and Partnerships at Elsevier Corporation, and as Vice President of Business Development at GE Healthcare. He holds a Juris Doctorate from Boston College.